310 related articles for article (PubMed ID: 31297674)
1. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Alvarado MD; Mittendorf EA; Teshome M; Thompson AM; Bold RJ; Gittleman MA; Beitsch PD; Blair SL; Kivilaid K; Harmer QJ; Hunt KK
Ann Surg Oncol; 2019 Oct; 26(11):3510-3516. PubMed ID: 31297674
[TBL] [Abstract][Full Text] [Related]
2. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study).
Vidya R; Khosla M; Laws S; Harvey J; Kaushik M; Mullapudi NA; Macmillan D
Surgeon; 2023 Apr; 21(2):128-134. PubMed ID: 35551871
[TBL] [Abstract][Full Text] [Related]
3. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.
Teshome M; Wei C; Hunt KK; Thompson A; Rodriguez K; Mittendorf EA
Ann Surg Oncol; 2016 May; 23(5):1508-14. PubMed ID: 26893221
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
5. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
6. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study.
Rubio IT; Rodriguez-Revuelto R; Espinosa-Bravo M; Siso C; Rivero J; Esgueva A
Eur J Surg Oncol; 2020 Dec; 46(12):2195-2201. PubMed ID: 32631710
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
8. Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial.
Man V; Suen D; Kwong A
Ann Surg Oncol; 2023 Jun; 30(6):3237-3244. PubMed ID: 36849573
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
10. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
11. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
[TBL] [Abstract][Full Text] [Related]
12. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial.
Douek M; Klaase J; Monypenny I; Kothari A; Zechmeister K; Brown D; Wyld L; Drew P; Garmo H; Agbaje O; Pankhurst Q; Anninga B; Grootendorst M; Ten Haken B; Hall-Craggs MA; Purushotham A; Pinder S;
Ann Surg Oncol; 2014 Apr; 21(4):1237-45. PubMed ID: 24322530
[TBL] [Abstract][Full Text] [Related]
14. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope.
Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
Breast; 2014 Apr; 23(2):175-9. PubMed ID: 24484967
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
16. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
[TBL] [Abstract][Full Text] [Related]
18. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
19. Sentinel Lymph Node Biopsy in Early Breast Cancer: Magnetic Tracer as the Only Localizing Agent.
Man V; Wong TT; Co M; Suen D; Kwong A
World J Surg; 2019 Aug; 43(8):1991-1996. PubMed ID: 30888473
[TBL] [Abstract][Full Text] [Related]
20. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
